Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Investigating the Effects of Psilocybin on Cognitive Flexibility in Touchscreen and Naturalistic Variations of the Probabilistic Reversal Learning TaskbioRxiv · 2026-08-12TRIP - TReatment to Improve Depression and/or Anxiety Using Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance TherapyClinicalTrials.gov · 2026-08-12TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer SurvivorsClinicalTrials.gov · 2026-08-12NeuroGuard: Psilocybin Trial for Preventing Chemo-induced NeuropathyClinicalTrials.gov · 2026-08-12Neural correlates of insight on psilocybin: a within-subjects, healthy volunteer studyJoCN Forum · 2026-05-08Trends in first-time psychedelic and other hallucinogen use in the United States: Results from the National Survey on Drug Use and Health.Drug and alcohol dependence · 2026-05-01Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial - CORRIGENDUMBJPsych Open · 2026-05-01PSilocybin for psYCHological and existential distress in PALliative care (PSYCHED-PAL): A single arm unblinded clinical trial.Palliative medicine · 2026-04-01Age moderates the relationship between psychedelics use and mental health in naturalistic settingsResearch Square · 2026-03-10Meaning and Psychedelics in Palliative Care: A Narrative Review.Journal of pain and symptom management · 2026-03-01Safety and Efficacy of Microdosing Psilocybin over 8 Weeks for Major Depressive Disorder: A Randomized Clinical TrialResearch Square · 2026-02-23Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial.BJPsych open · 2026-02-16Facing Mortality Together: A Constructivist Grounded Theory Analysis of Group Psilocybin Therapy Among Older Long-Term AIDS Survivor Gay MenPalliative Medicine Reports · 2026-01-01Indigenous Knowledge Systems & Psychedelic Science: Towards Ethical and Reciprocal Collaboration.Journal of psychopharmacology (Oxford, England) · 2026-01-01Meaning and Purpose Therapy Modified for Psilocybin (P-MaP): A Treatment Model for Palliative Care PatientsJournal of Health Service Psychology · 2025-12-01Microdosing Psilocybin for Major Depressive Disorder: Study Protocol for a Phase II Double-Blind Placebo-Controlled Randomized Partial Crossover TrialPsyArXiv · 2025-11-16Psychedelic Augmentation of 12-Step Engagement: A Novel, Accessible Approach to Enhance Community-Based Recovery from Substance Use Disorders.Journal of psychoactive drugs · 2025-11-10Gestational LSD exposure in mouse rapidly reaches embryonic CSF and is associated with altered choroid plexus signaling, cerebral cortical development, and offspring behaviorbioRxiv · 2025-10-01US Poison Center Encounters for Psilocybin-Related Exposures: 2013-2022.Journal of the American College of Emergency Physicians open · 2025-10-01Latent Classes of Lifetime Use of Seven Hallucinogens in the United States.Journal of psychoactive drugs · 2025-08-04Comparing psilocybin to metformin as neuroprotective agents against Parkinson's dementia: A systematic review of evidence and efficacy.Progress in neuro-psychopharmacology & biological psychiatry · 2025-01-10Psychedelics as a tool for a more connected and sustainable world? Considering the importance of rituals, boundaries, and commitment.The International journal on drug policy · 2024-11-01Psilocybin-assisted therapy and HIV-related shame.Scientific reports · 2024-08-02From Venerable Cultural Practices to Modern Psychological Solutions: Enter Entheogens into Mainstream MedicineEuropean Journal of Arts Humanities and Social Sciences · 2024-05-01Misinterpretations and Omissions: A Critical Response to Goodwin and Colleagues' Commentary on Psilocybin-Assisted Therapy.The American journal of psychiatry · 2024-01-01Older adults in psychedelic-assisted therapy trials: A systematic review.Journal of psychopharmacology (Oxford, England) · 2024-01-01Keeping the promise: a critique of the current state of microdosing research.Frontiers in psychiatry · 2024-01-01Commentary: Evidence-Informed Recommendation to Achieve Approximate Parity in the Allowed Number of Doses for Common Psychedelics.Journal of psychoactive drugs · 2024-01-01The Safety and Efficacy of Psychedelic-Assisted Therapies for Older Adults: Knowns and Unknowns.The American journal of geriatric psychiatry: official journal of the American Association for Geriatric Psychiatry · 2023-01-01Policy considerations that support equitable access to responsible, accountable, safe, and ethical uses of psychedelic medicines.Neuropharmacology · 2022-11-15If the Doors of Perception Were Cleansed, Would Chronic Pain be Relieved? Evaluating the Benefits and Risks of Psychedelics.The journal of pain · 2022-10-01Special considerations for evaluating psilocybin-facilitated psychotherapy in vulnerable populations.Neuropharmacology · 2022-08-15Microdosing psychedelics: Subjective benefits and challenges, substance testing behavior, and the relevance of intention.Journal of psychopharmacology (Oxford, England) · 2022-01-01The Potential of Psychedelics for End of Life and Palliative Care.Current topics in behavioral neurosciences · 2022-01-01Comment and Response: (Lugo-Radillo & Cortez-Lopez, 2020) Long-Term Amelioration of OCD Symptoms in a Patient with Chronic Consumption of Psilocybin-Containing Mushrooms.Journal of psychoactive drugs · 2022-01-01Participant Reports of Mindfulness, Posttraumatic Growth, and Social Connectedness in Psilocybin-Assisted Group Therapy: An Interpretive Phenomenological AnalysisJournal of Humanistic Psychology · 2021-06-12Psilocybin-Assisted Group Therapy and Attachment: Observed Reduction in Attachment Anxiety and Influences of Attachment Insecurity on the Psilocybin Experience.ACS pharmacology & translational science · 2021-04-09Investigation of the Structure-Activity Relationships of Psilocybin Analogues.ACS pharmacology & translational science · 2021-04-09Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study.EClinicalMedicine · 2020-10-01Microdosing psychedelics: Demographics, practices, and psychiatric comorbidities.Journal of psychopharmacology (Oxford, England) · 2020-06-01Global Drug SurveyPsyArXiv · 2020-04-12Global Drug SurveyPsyArXiv · 2020-04-12Psychedelic Research and the Need for Transparency: Polishing Alice's Looking Glass.Frontiers in psychology · 2020-01-01Psychedelic microdosing benefits and challenges: an empirical codebook.Harm reduction journal · 2019-07-10T137. Psilocybin-Assisted Group Therapy for Demoralization in Long-Term AIDS SurvivorsBiological Psychiatry · 2019-04-30Microdosing psychedelics: personality, mental health, and creativity differences in microdosers.Psychopharmacology · 2019-02-01Psychedelic-Assisted Group Therapy: A Systematic Review.Journal of psychoactive drugs · 2019-01-01Does getting high hurt? Characterization of cases of LSD and psilocybin-containing mushroom exposures to national poison centers between 2000 and 2016.Journal of psychopharmacology (Oxford, England) · 2018-12-01Microdosing Psychedelics: Personality, mental health, and creativity differences in microdosersPsyArXiv · 2018-11-02Microdosing Psychedelics: Personality, mental health, and creativity differences in microdosersPsyArXiv · 2018-11-02